SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Northwest Biotherapeutics Inc.
NWBO 0.285-2.2%Feb 3 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John McCarthy who wrote (47)8/22/2006 5:06:32 AM
From: zeta1961   of 760
 
Detailed paper on NWBT's P1 glioblastoma vaccine..very interesting for those more inclined toward immunotherapeutic route..

Quite importantly, to evaluate P2 trial methodology, although they enrolled patients 'as they came,' those needing steroids like dexamethasone were excluded..this criterium naturally selects for patients with tumors in less harmful parts of the brain and for those who most of the tumor was excised..they admitted this in this piece..
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News